Sign in to view content

Cell Therapies for Atrophic AMD

Allen C Ho, MD FASRS

Video
Published 2020

Related

Phase IIIb TALON study of brolucizumab versus aflibercept in a matched treat-and-extend regimen to treat neovascular AMD: 32-week primary outcomes
Carl D. Regillo, MD
Annual Meeting Talks
2022
Role of Metabolomics in Age-Related Macular Degeneration
Deeba Husain, MD
Annual Meeting Talks
2020
Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa: Results from the Phase 2b Trial
Anthony Joseph, MD
Annual Meeting Talks
2020

Category: Age-Related Macular Degeneration

See more